Switch to:
More From Other Websites
7:09 am Myriad Genetics announces new data demonstrating the utility of the Prolaris test to more... Feb 20 2017
Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with... Feb 17 2017
Myriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men... Feb 17 2017
Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : February... Feb 14 2017
MYRIAD GENETICS INC Financials Feb 11 2017
Myriad Genetics to Join S&P SmallCap 600 Feb 10 2017
Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017 Feb 09 2017
Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag Feb 09 2017
MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report Feb 08 2017
Wednesday’s Biggest Biopharma Movers Feb 08 2017
Myriad Genetics: Fairly Valued? Feb 08 2017
Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments Feb 08 2017
Stocks Open Lower; Myriad, Microchip, Inphi Climb Feb 08 2017
Myriad Genetics (MYGN) Beats on Q2 Earnings, Narrows View Feb 08 2017
Myriad Genetics upgraded by Ladenburg Thalmann Feb 08 2017
Edited Transcript of MYGN earnings conference call or presentation 7-Feb-17 9:30pm GMT Feb 08 2017
Myriad beats Street 2Q forecasts Feb 07 2017
Myriad beats Street 2Q forecasts Feb 07 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK